Catalog No.
RVV00320
Species reactivity
SARS-CoV-2(2019-nCoV)
Host species
Human
Isotype
IgA
Clonality
Monoclonal
Target
Receptor-Binding Domain, RBD, Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, S, SARS-CoV-2, 2019-nCoV
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein L purified from cell culture supernatant.
Accession
P0DTC2-2
Applications
ELISA, Neutralization
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
S309
Lactoferrin and SIgA Concentrations in Human Milk of SARS-CoV-Infected Mothers-Polish Cohort Study., PMID:40507109
The effect of early COVID-19 treatment with convalescent plasma on antibody responses to SARS-CoV-2., PMID:40488473
Exploring the standardized detection and sampling methods of human nasal SARS-CoV-2 RBD IgA., PMID:40463384
Individuals Infected with SARS-CoV-2 Prior to COVID-19 Vaccination Maintain Vaccine-Induced RBD-Specific Antibody Levels and Viral Neutralization Activity for One Year., PMID:40431652
Construction of a variable fragment (Fv)-immunoglobulin A (IgA) anti-receptor binding domain (RBD) SARS-CoV-2 library based on IgA from Indonesian COVID-19 survivors., PMID:40403817
The Combination of TLR4 and TLR9 Agonists with Self-Amplifying RNA Lipid Nanoparticles Leads to a More Powerful Immune Response Against SARS-CoV-2., PMID:40401447
An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters., PMID:40383816
Establishment of a novel adjuvant screening system for the development of intranasal vaccine adjuvants., PMID:40383081
Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-19 vaccination., PMID:40382525
Compartmentalised mucosal and blood immunity to SARS-CoV-2 is associated with high seroprevalence before the Delta wave in Africa., PMID:40379979
Comparative performance of serum and plasma samples in SARS-CoV-2 serology and neutralization assays., PMID:40374015
Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice., PMID:40360777
Comprehensive analysis of human coronavirus antibody responses in ICU and non-ICU COVID-19 patients reveals IgG3 against SARS-CoV-2 spike protein as a key biomarker of disease severity., PMID:40359129
Mimicking immune complexes for efficient antibody responses., PMID:40356891
Regulatory cytokines modulate early isotype-specific response associated with COVID-19 survival., PMID:40342417
Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein., PMID:40338637
Systemic and Mucosal Antibody Responses to SARS-CoV-2 Variant-Specific Prime-and-Boost and Prime-and-Spike Vaccination: A Comparison of Intramuscular and Intranasal Bivalent Vaccine Administration in a Murine Model., PMID:40333249
Increased serum levels of IL-40 are associated with IgA and NETosis biomarkers in Covid-19 patients: IL-40 and infectious diseases., PMID:40315230
Minimal Impact of Prior Common Cold Coronavirus Exposure on Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination or Infection Risk in Older Adults in Congregate Care., PMID:40313478
An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models., PMID:40312392
Mucosal immune responses to SARS-CoV-2 infection and COVID-19 vaccination., PMID:40311214
Dynamic Changes in Antibodies and Proteome in Breast Milk of Mothers Infected with Wild-Type SARS-CoV-2 and Omicron: A Longitudinal Study., PMID:40284260
Effect of heterologous intranasal iNCOVACC® vaccination as a booster to two-dose intramuscular Covid-19 vaccination series: a randomized phase 3 clinical trial., PMID:40269252
Cord blood IgA/M reveals in utero response to SARS-CoV-2 with fluctuations in relation to circulating variants., PMID:40229328
Exploring TLR agonists as adjuvants for COVID-19 oral vaccines., PMID:40184639
Study protocol for a randomised controlled trial evaluating the efficacy of dietary modulation of probiotics on nutritional status and antibody response to SARS-CoV-2 in Indonesian adolescents: gut-lung axis (DIVINE)., PMID:40180370
Virus-specific antibody responses in severe acute respiratory syndrome coronavirus 2-infected and vaccinated individuals., PMID:40157431
An institutional COVID-19 initiative: creation of a biobank and serological data analysis in pre- and post-vaccination cohorts., PMID:40136202
A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates., PMID:40116506
Orally Antigen-Engineered Yeast Vaccine Elicits Robust Intestinal Mucosal Immunity., PMID:40082064
Exploring the standardization of human nasal antibody measurements., PMID:40071971
Bacterial lysates in modifying sIgA levels in the upper respiratory tract in COVID-19 patients., PMID:40065113
The effect of the pandemic on autoantibody rates in the general population., PMID:40060139
Prior SARS-CoV-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster., PMID:40044048
Thymic stromal lymphopoietin improves protective immunity of the SARS-CoV-2 subunit vaccine by inducing dendritic cell-dependent germinal center response., PMID:40035515
Immune imprinting and vaccination interval underly XBB.1.5 monovalent vaccine immunogenicity., PMID:40034787
Nasal delivery of secretory IgA confers enhanced neutralizing activity against Omicron variants compared to its IgG counterpart., PMID:40025736
Impact of maternal COVID-19 infection on offspring immunity and maternal-fetal outcomes at different pregnancy stages: a cohort study., PMID:40022096
Rheumatoid arthritis-associated rheumatoid factors post-COVID-19., PMID:40018049
Investigation of Perceived Stress During COVID-19 Pandemic Self-Isolation Periods., PMID:40005293
Association of infection-induced antibody levels with risk of subsequent SARS-COV-2 reinfection among healthcare professionals, Rhode Island, 1 March 2020-17 February 2021., PMID:39998388
Viral and immune profiles during the first wave of SARS-CoV-2 infection in hospitalized patients in Sardinia, Italy., PMID:39994243
Intranasal recombinant protein subunit vaccine targeting TLR3 induces respiratory tract IgA and CD8 T cell responses and protects against respiratory virus infection., PMID:39983329
Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection., PMID:39950298
Validation and clinical performance of a non-commercial ELISA for SARS-CoV-2 anti-RBD IgA antibodies., PMID:39894142
Supplementation with heat-sterilized Lactobacillus crispatus strain KT-11 stimulates the T cell-related immune function of healthy Japanese adults: A pilot randomized, placebo-controlled, double-blind, parallel-group study., PMID:39889684
mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity., PMID:39887249
Maternal obesity associates with altered humoral immunity in blood and colostrum., PMID:39870213
Characterization of Vaccine-Enhanced Humoral Immune Responses Against Emergent SARS-CoV-2 Variants in a Convalescent Cohort., PMID:39861005
For research use only. Not for human or drug use.
